Stockreport

ADC Therapeutics S.A. Investigated by the Portnoy Law Firm

ADC Therapeutics SA Common Shares  (ADCT) 
PDF LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ADC Therapeutics S.A., (“ADC" or the "Company") (NYSE: ADCT) investors that the firm has i [Read more]